Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |